Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Clinical trial NCT00607451 · TERMINATED
Trial details
- NCT number
- NCT00607451
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2016-08-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.